Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06576661 · ClinicalTrials.gov registry record · NA
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
A NA study of Kidney Stone and Nephrolithiasis, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06576661: Recruiting NA study of Kidney Stone and Nephrolithiasis, sponsored by University of Kansas Medical Center.
NCT06576661 is a NA study of Kidney Stone and Nephrolithiasis that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 80 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06576661, a NA study of Kidney Stone and Nephrolithiasis, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.
Primary Outcome
Treating investigators will be evaluated using the modified NOTSS tool during the procedure. The NOTSS is used to measure non-technical skills in the operation room in the following categories; situation awareness, decision making, communication \& teamwork, and leadership.
Conditions Studied
Interventions
- DEVICE INTRARENAL PRESSURE MONITORING VISIBLE
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-01-28 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT06576661 shows while recruiting
NCT06576661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which INTRARENAL PRESSURE MONITORING VISIBLE is the first listed.
NCT06576661 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06576661 about?
NCT06576661 is a clinical study titled "Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes". The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.
What is the current status of trial NCT06576661?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-01-28. Estimated completion is 2025-12-01.
What conditions does trial NCT06576661 study?
This clinical trial studies the following conditions: Kidney Stone, Nephrolithiasis.
What interventions are being tested in trial NCT06576661?
The interventions under investigation include: INTRARENAL PRESSURE MONITORING VISIBLE (DEVICE).
Who is sponsoring clinical trial NCT06576661?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06576661 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06576661's enrollment target sits among peer trials
80 12th of 28 higher than 15 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI